secwatch / observer
8-K filed September 13, 2024, 7:59 PM ET ticker KYNB CIK 0000921299
leadership confidence high sentiment neutral materiality 0.40

FibroGen directors Blaug, Cravatt, Lema resign effective Sept 30; committees reassigned

KYNTRA BIO, INC.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Suzanne Blaug

Director
KYNB · KYNTRA BIO, INC.
Effective
2024-09-30
Filed
September 13, 2024, 7:59 PM ET
On September 12, 2024, Suzanne Blaug, Benjamin Cravatt, and Gerald Lema each provided to the Board of Directors (the “Board”) notification of their resignations from the Board of FibroGen, Inc. (the “Company”), effective September 30, 2024.
Departed

Gerald Lema

Director
KYNB · KYNTRA BIO, INC.
Effective
2024-09-30
Filed
September 13, 2024, 7:59 PM ET
On September 12, 2024, Suzanne Blaug, Benjamin Cravatt, and Gerald Lema each provided to the Board of Directors (the “Board”) notification of their resignations from the Board of FibroGen, Inc. (the “Company”), effective September 30, 2024.
Departed

Benjamin Cravatt

Director
KYNB · KYNTRA BIO, INC.
Effective
2024-09-30
Filed
September 13, 2024, 7:59 PM ET
On September 12, 2024, Suzanne Blaug, Benjamin Cravatt, and Gerald Lema each provided to the Board of Directors (the “Board”) notification of their resignations from the Board of FibroGen, Inc. (the “Company”), effective September 30, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Suzanne Blaug resigned as Director at KYNTRA BIO, INC..

Action
resigned
Role
Director
Exact text from the filing
On September 12, 2024, Suzanne Blaug, Benjamin Cravatt, and Gerald Lema each provided to the Board of Directors (the “Board”) notification of their resignations from the Board of FibroGen, Inc. (the “Company”), effective September 30, 2024.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Gerald Lema resigned as Director at KYNTRA BIO, INC..

Action
resigned
Role
Director
Exact text from the filing
On September 12, 2024, Suzanne Blaug, Benjamin Cravatt, and Gerald Lema each provided to the Board of Directors (the “Board”) notification of their resignations from the Board of FibroGen, Inc. (the “Company”), effective September 30, 2024.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Benjamin Cravatt resigned as Director at KYNTRA BIO, INC..

Action
resigned
Role
Director
Exact text from the filing
On September 12, 2024, Suzanne Blaug, Benjamin Cravatt, and Gerald Lema each provided to the Board of Directors (the “Board”) notification of their resignations from the Board of FibroGen, Inc. (the “Company”), effective September 30, 2024.
View on SEC.gov

KYNTRA BIO, INC. filing history →

Source: SEC EDGAR
accession 0000950170-24-106359
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.